INTEGRATED BIOPHARMA INC Quarterly Operating Lease, Payments in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Integrated Biopharma Inc quarterly/annual Operating Lease, Payments history and growth rate from Q3 2018 to Q3 2024.
  • Integrated Biopharma Inc Operating Lease, Payments for the quarter ending September 30, 2024 was $236K, a 10.9% decline year-over-year.
  • Integrated Biopharma Inc annual Operating Lease, Payments for 2024 was $1.06M, a 7.28% increase from 2023.
  • Integrated Biopharma Inc annual Operating Lease, Payments for 2023 was $989K, a 52.2% increase from 2022.
  • Integrated Biopharma Inc annual Operating Lease, Payments for 2022 was $650K, a 2.11% decline from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $236K -$29K -10.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q3 2023 $265K +$37K +16.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q3 2022 $228K +$61K +36.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q3 2021 $167K +$2K +1.21% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q3 2020 $165K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q3 2019 $165K +$47K +39.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q3 2018 $118K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.